← Back to Clinical Trials
Recruiting NCT06725966

Personalized Treatment of Refractory BPPV

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Benign Paroxysmal Positional Vertigo
Sponsor Hospital Clinico Universitario de Santiago
Study Type INTERVENTIONAL
Phase N/A
Enrollment 54
Sex ALL
Min Age 18 Years
Max Age 100 Years
Start Date 2024-07-01
Completion 2026-06-30
Interventions
Conventional Epley maneuverPersonalized Epley maneuver

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Background: Benign paroxysmal positional vertigo (BPPV) is the most common cause of vertigo, often effectively treated with standard canalith repositioning maneuvers (CRMs). However, approximately 12.5% of cases remain refractory, leading to persistent symptoms and increased healthcare burden. Variations in the anatomical orientation of the semicircular canals (SCCs) may explain the resistance to conventional maneuvers. This study explores a personalized medicine approach, utilizing computational fluid dynamics (CFD) based on MRI reconstructions to tailor CRMs with the help of mechanical rotation chair according to individual inner ear anatomy. Methods: The investigators conducted a randomized, multicenter, open-label study targeting patients with refractory posterior canal BPPV. Participants were allocated to either a control group (receiving repeated standard CRMs and Brandt-Daroff exercises) or an intervention group (receiving personalized CRMs based on CFD simulations derived from MRI scans). The intervention group's maneuvers were executed using a mechanical rotational chair designed for precise angulation. Primary outcomes included resolution of nystagmus and vertigo symptoms, while secondary outcomes measured the reduction in healthcare visits and improved quality of life (Dizziness Handicap Inventory score).

Eligibility Criteria

Inclusion Criteria: * A. Diagnosed with BPPVp according to the Barany Society criteria: 1. Recurrent episodes of vertigo or positional instability, triggered by lying down or turning the head in the supine position. 2. Episodes lasting less than 1 minute. 3. Positional nystagmus observed after a latency period during the Dix-Hallpike test (DHT), with an upward vertical component and a torsional component (clockwise on the left side and counterclockwise on the right). 4. Symptoms not explained by any other cause. AND * B. Refractory to otolith repositioning maneuvers (Epley and/or Semont maneuvers), with persistence of symptoms after three attempts. Exclusion Criteria: * Cognitive impairment that prevents understanding of their condition and the required procedures. * Pathological conditions that hinder the execution of the maneuvers. * BPPV involving canals other than the posterior canal or bilateral posterior canal involvement. * Low educational level, which may impede understanding o

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}